Pulmonary manifestations of inflammatory bowel disease

World Journal of Gastroenterology

Volumn 20, Issue 37, 2014, Pages 13501-13511

  Ji, Xiao Qing ^a   Wang, Li Xia ^b   Lu, De Gan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b LIAOCHENG PEOPLE'S HOSPITAL   (China)

Author keywords

Crohn's disease; Inflammatory bowel diseases; Lung diseases; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ANTIINFLAMMATORY AGENT; BIOLOGICAL PRODUCT; GASTROINTESTINAL AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLOSIS; BIOLOGICAL THERAPY; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; COCCIDIOIDOMYCOSIS; COUGHING; DIGESTIVE SYSTEM FISTULA; DISEASE ASSOCIATION; DRUG FEVER; DRUG HYPERSENSITIVITY; DYSPNEA; EOSINOPHILIA; HUMAN; INFLAMMATORY BOWEL DISEASE; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LOEFFLER PNEUMONIA; LUNG ALVEOLITIS; LUNG DISEASE; LUNG EDEMA; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG GRANULOMA; LUNG HEMORRHAGE; LUNG INJURY; LUNG PARENCHYMA; LUNG TOXICITY; OPPORTUNISTIC INFECTION; PLEURA DISEASE; PNEUMOCYSTIS PNEUMONIA; RESPIRATORY FUNCTION DISORDER; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT FISTULA; STEROID THERAPY; SYSTEMIC THERAPY; THORAX PAIN; THROMBOEMBOLISM; CHEMICALLY INDUCED; COMPLICATION; INFLAMMATORY BOWEL DISEASES; LUNG DISEASES; PREDICTIVE VALUE; RISK FACTOR; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; BIOLOGICAL PRODUCTS; GASTROINTESTINAL AGENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; LUNG DISEASES; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84910000511     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i37.13501     Document Type: Article

References (180)

1. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976; 55: 401-412 [PMID: 957999]
2. Rankin GB. Extraintestinal and systemic manifestations of inflammatory bowel disease. Med Clin North Am 1990; 74: 39-50 [PMID: 2404180]
3. Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 2002; 31: 307-327 [PMID: 12122740 DOI: 10.1016/S0889-8553(01)00019-X]
4. Rankin GB, Watts HD, Melnyk CS, Kelley ML. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 1979; 77: 914-920 [PMID: 467943]
5. Larsen S, Bendtzen K, Nielsen OH. Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management. Ann Med 2010; 42: 97-114 [PMID: 20166813 DOI: 10.3109/07853890903559724]
6. Williams H, Walker D, Orchard TR. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep 2008; 10: 597-605 [PMID: 19006617 DOI: 10.1007/s11894-008-0108-6]
7. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996; 23: 29-34 [PMID: 8835896 DOI: 10.1097/00004836-199607000-00009]
8. Camus P, Piard F, Ashcroft T, Gal AA, Colby TV. The lung in inflammatory bowel disease. Medicine (Baltimore) 1993; 72: 151-183 [PMID: 8502168 DOI: 10.1097/00005792-199372030-00003]
9. Loftus EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517 [PMID: 15168363 DOI: 10.1053/j.gastro.2004.01.063]
10. Hoffmann RM, Kruis W. Rare extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2004; 10: 140-147 [PMID: 15168815 DOI: 10.1097/00054725-200403000-00013]
11. Turner-Warwick M. Fibrosing alveolitis and chronic liver disease. Q J Med 1968; 37: 133-149 [PMID: 4872529]
12. Kraft SC, Earle RH, Roesler M, Esterly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 1976; 136: 454-459 [PMID: 1267553 DOI: 10.1001/archinte.136.4.454]
13. Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 2007; 131: 524-532 [PMID: 17296657]
14. Tzanakis NE, Tsiligianni IG, Siafakas NM. Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol 2010; 16: 299-305 [PMID: 20082474 DOI: 10.3748/wjg.v16.i3.299]
15. Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2003; 9: 104-115 [PMID: 12769444 DOI: 10.1097/00054725-200303000-00004]
16. Casey MB, Tazelaar HD, Myers JL, Hunninghake GW, Kakar S, Kalra SX, Ashton R, Colby TV. Noninfectious lung pathology in patients with Crohn's disease. Am J Surg Pathol 2003; 27: 213-219 [PMID: 12548168 DOI: 10.1097/00000478-200302000-00010]
17. Camus P, Colby TV. The lung in inflammatory bowel disease. Eur Respir J 2000; 15: 5-10 [PMID: 10678613 DOI: 10.118 3/09031936.00.15100500]
18. Spira A, Grossman R, Balter M. Large airway disease associated with inflammatory bowel disease. Chest 1998; 113: 1723-1726 [PMID: 9631822 DOI: 10.1378/chest.113.6.1723]
19. Douglas JG, McDonald CF, Leslie MJ, Gillon J, Crompton GK, McHardy GJ. Respiratory impairment in inflammatory bowel disease: does it vary with disease activity? Respir Med 1989; 83: 389-394 [PMID: 2616823 DOI: 10.1016/ S0954-6111(89)80070-8]
20. Kuzela L, Vavrecka A, Prikazska M, Drugda B, Hronec J, Senkova A, Drugdova M, Oltman M, Novotna T, Brezina M, Kratky A, Kristufek P. Pulmonary complications in patients with inflammatory bowel disease. Hepatogastroenterology 1999; 46: 1714-1719 [PMID: 10430329]
21. Marvisi M, Bassi E, Civardi G. Pulmonary involvement in inflammatory bowel disease. Curr Drug Targets Inflamm Allergy 2004; 3: 437-439 [PMID: 15584891 DOI: 10.2174/1568010042634514]
22. Calder CJ, Lacy D, Raafat F, Weller PH, Booth IW. Crohn' s disease with pulmonary involvement in a 3 year old boy. Gut 1993; 34: 1636-1638 [PMID: 8244155 DOI: 10.1136/gut.34.11.1636]
23. Betancourt SL, Palacio D, Jimenez CA, Martinez S, Marom EM. Thoracic manifestations of inflammatory bowel disease. AJR Am J Roentgenol 2011; 197: W452-W456 [PMID: 21862772 DOI: 10.2214/AJR.10.5353]
24. Rogers BH, Clark LM, Kirsner JB. The epidemiologic and demographic characteristics of inflammatory bowel disease: an analysis of a computerized file of 1400 patients. J Chronic Dis 1971; 24: 743-773 [PMID: 5146188 DOI: 10.1016/0021-968 1(71)90087-7]
25. Weatherhead M, Masson S, Bourke SJ, Gunn MC, Burns GP. Interstitial pneumonitis after infliximab therapy for Crohn's disease. Inflamm Bowel Dis 2006; 12: 427-428 [PMID: 16670533]
26. Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 2006; 12: 4819-4831 [PMID: 16937463]
27. Songür N, Songür Y, Tüzün M, Doʇan I, Tüzün D, Ensari A, Hekimoglu B. Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease. J Clin Gastroenterol 2003; 37: 292-298 [PMID: 14506385]
28. van Lierop PP, Samsom JN, Escher JC, Nieuwenhuis EE. Role of the innate immune system in the pathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009; 48: 142-151 [PMID: 19179875 DOI: 10.1097/ MPG.0b013e3181821964]
29. Higenbottam T, Cochrane GM, Clark TJ, Turner D, Millis R, Seymour W. Bronchial disease in ulcerative colitis. Thorax 1980; 35: 581-585 [PMID: 7444824 DOI: 10.1136/thx.35.8.581]
30. Marvisi M, Fornasari G. [Is the lung a target organ in inflammatory bowel disease?]. Recenti Prog Med 2001; 92: 774-777 [PMID: 11822102]
31. MacDermott RP, Schloemann SR, Bertovich MJ, Nash GS, Peters M, Stenson WF. Inhibition of antibody secretion by 5-aminosalicylic acid. Gastroenterology 1989; 96: 442-448 [PMID: 2562949]
32. Mahadeva R, Walsh G, Flower CD, Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000; 15: 41-48 [PMID: 10678619 DOI: 10.1183/09031936.00.15104100]
33. Butland RJ, Cole P, Citron KM, Turner-Warwick M. Chronic bronchial suppuration and inflammatory bowel disease. Q J Med 1981; 50: 63-75 [PMID: 7267968]
34. Gibb WR, Dhillon DP, Zilkha KJ, Cole PJ. Bronchiectasis with ulcerative colitis and myelopathy. Thorax 1987; 42: 155-156 [PMID: 3433242 DOI: 10.1136/thx.42.2.155]
35. Pang JA, Vicary FR. Carcinoma of the colon, sclerosing cholangitis, pericholangitis, and bronchiectasis in a patient with chronic ulcerative colitis. J Clin Gastroenterol 1984; 6: 361-363 [PMID: 6481120]
36. Moles KW, Varghese G, Hayes JR. Pulmonary involvement in ulcerative colitis. Br J Dis Chest 1988; 82: 79-83 [PMID: 3048360 DOI: 10.1016/0007-0971(88)90012-5]
37. Gionchetti P, Schiavina M, Campieri M, Fabiani A, Cornia BM, Belluzzi A, Brignola C, Iannone P, Miglioli M, Barbara L. Bronchopulmonary involvement in ulcerative colitis. J Clin Gastroenterol 1990; 12: 647-650 [PMID: 2266241 DOI: 10.1097/00004836-199012000-00010]
38. Lamblin C, Copin MC, Billaut C, Marti R, Tacq V, Riviere O, Wallaert B. Acute respiratory failure due to tracheobronchial involvement in Crohn's disease. Eur Respir J 1996; 9: 2176-2178 [PMID: 8902486 DOI: 10.1183/09031936.96.09102176]
39. Eaton TE, Lambie N, Wells AU. Bronchiectasis following colectomy for Crohn's disease. Thorax 1998; 53: 529-531 [PMID: 9713458 DOI: 10.1136/thx.53.6.529]
40. Garg K, Lynch DA, Newell JD. Inflammatory airways disease in ulcerative colitis: CT and high-resolution CT features. J Thorac Imaging 1993; 8: 159-163 [PMID: 8315712 DOI: 10.1097/00005382-199321000-00010]
41. Wilcox P, Miller R, Miller G, Heath J, Nelems B, Muller N, Ostrow D. Airway involvement in ulcerative colitis. Chest 1987; 92: 18-22 [PMID: 3595232 DOI: 10.1378/chest.92.1.18]
42. Vasishta S, Wood JB, McGinty F. Ulcerative tracheobronchitis years after colectomy for ulcerative colitis. Chest 1994; 106: 1279-1281 [PMID: 7924516 DOI: 10.1378/chest.106.4.1279]
43. Rickli H, Fretz C, Hoffman M, Walser A, Knoblauch A. Severe inflammatory upper airway stenosis in ulcerative colitis. Eur Respir J 1994; 7: 1899-1902 [PMID: 7828702 DOI: 10.1183/09031936.94.07101899]
44. Kuźniar T, Sleiman C, Brugière O, Groussard O, Mal H, Mellot F, Pariente R, Malolepszy J, Fournier M. Severe tracheobronchial stenosis in a patient with Crohn's disease. Eur Respir J 2000; 15: 209-212 [PMID: 10678648]
45. Shad JA, Sharieff GQ. Tracheobronchitis as an initial presentation of ulcerative colitis. J Clin Gastroenterol 2001; 33: 161-163 [PMID: 11468448 DOI: 10.1097/00004836-200108000-00016]
46. Lemann M, Messing B, D'Agay F, Modigliani R. Crohn' s disease with respiratory tract involvement. Gut 1987; 28: 1669-1672 [PMID: 3428695 DOI: 10.1136/gut.28.12.1669]
47. Vandenplas O, Casel S, Delos M, Trigaux JP, Melange M, Marchand E. Granulomatous bronchiolitis associated with Crohn's disease. Am J Respir Crit Care Med 1998; 158: 1676-1679 [PMID: 9817724 DOI: 10.1164/ajrccm.158.5.9801070]
48. Desai SJ, Gephardt GN, Stoller JK. Diffuse panbronchiolitis preceding ulcerative colitis. Chest 1989; 95: 1342-1344 [PMID: 2721273 DOI: 10.1378/chest.95.6.1342]
49. Hilling GA, Robertson DA, Chalmers AH, Rigby HS. Unusual pulmonary complication of ulcerative colitis with a rapid response to corticosteroids: case report. Gut 1994; 35: 847-848 [PMID: 8020818 DOI: 10.1136/gut.35.6.847]
50. Shneerson JM. Lung bullae, bronchiectasis, and Hashimoto' s disease associated with ulcerative colitis treated by colectomy. Thorax 1981; 36: 313-314 [PMID: 6895127 DOI: 10.1136/thx.36.4.313]
51. Raj AA, Birring SS, Green R, Grant A, de Caestecker J, Pavord ID. Prevalence of inflammatory bowel disease in patients with airways disease. Respir Med 2008; 102: 780-785 [PMID: 18321696 DOI: 10.1016/j.rmed.2007.08.014]
52. Karasalihoʇlu A, Kutlu K, Yilmaz T. Laryngotracheal obstruction in ulcerative colitis (apropos of a case). Rev Laryngol Otol Rhinol (Bord) 1988; 109: 469-471 [PMID: 3073480]
53. Janssen WJ, Bierig LN, Beuther DA, Miller YE. Stridor in a 47-year-old man with inflammatory bowel disease. Chest 2006; 129: 1100-1106 [PMID: 16608963 DOI: 10.1378/chest.129.4.1100]
54. Foster RA, Zander DS, Mergo PJ, Valentine JF. Mesalaminerelated lung disease: clinical, radiographic, and pathologic manifestations. Inflamm Bowel Dis 2003; 9: 308-315 [PMID: 14555914 DOI: 10.1097/00054725-200309000-00004]
55. Alcázar Navarrete B, Quiles Ruiz-Rico N, González Vargas F, Cabrera Torres L. [Bronchiectasis following colectomy in a patient with ulcerative colitis and factor V Leiden mutation]. Arch Bronconeumol 2005; 41: 230-232 [PMID: 15826533 DOI: 10.1016/S1579-2129(06)60428-X]
56. Basseri B, Enayati P, Marchevsky A, Papadakis KA. Pulmonary manifestations of inflammatory bowel disease: case presentations and review. J Crohns Colitis 2010; 4: 390-397 [PMID: 21122534 DOI: 10.1016/j.crohns.2010.03.008]
57. Cohen M, Sahn SA. Bronchiectasis in systemic diseases. Chest 1999; 116: 1063-1074 [PMID: 10531174]
58. Ward H, Fisher KL, Waghray R, Wright JL, Card SE, Cockcroft DW. Constrictive bronchiolitis and ulcerative colitis. Can Respir J 1999; 6: 197-200 [PMID: 10322103]
59. Veloso FT, Rodrigues H, Aguiar MM. Bronchiolitis obliterans in ulcerative colitis. J Clin Gastroenterol 1994; 19: 339-341 [PMID: 7876520 DOI: 10.1097/00004836-199412000-00019]
60. Bentur L, Lachter J, Koren I, Ben-Izhak O, Lavy A, Bentur Y, Rosenthal E. Severe pulmonary disease in association with Crohn's disease in a 13-year-old girl. Pediatr Pulmonol 2000; 29: 151-154 [PMID: 10639206]
61. Papiris SA, Malagari K, Manali ED, Kolilekas L, Triantafillidou C, Baou K, Rontogianni D, Bouros D, Kagouridis K. Bronchiolitis: adopting a unifying definition and a comprehensive etiological classification. Expert Rev Respir Med 2013; 7: 289-306 [PMID: 23734650 DOI: 10.1586/ers.13.21]
62. Serrano J, Plaza V, Franquet T, Giménez A, Rubio J. [Bronchiolitis associated with ulcerative colitis]. Arch Bronconeumol 1996; 32: 151-154 [PMID: 8634796]
63. Kubota Y, Hosogi S, Iwasaki Y. [A case of Crohn's disease with broncho-bronchiolitis]. Nihon Kokyuki Gakkai Zasshi 2004; 42: 655-659 [PMID: 15357269]
64. Trow TK, Morris DG, Miller CR, Homer RJ. Granulomatous bronchiolitis of Crohn's disease successfully treated with inhaled budesonide. Thorax 2009; 64: 546-547 [PMID: 19478123 DOI: 10.1136/thx.2008.107185]
65. Alrashid AI, Brown RD, Mihalov ML, Sekosan M, Pastika BJ, Venu RP. Crohn's disease involving the lung: resolution with infliximab. Dig Dis Sci 2001; 46: 1736-1739 [PMID: 11508676]
66. Heatley RV, Thomas P, Prokipchuk EJ, Gauldie J, Sieniewicz DJ, Bienenstock J. Pulmonary function abnormalities in patients with inflammatory bowel disease. Q J Med 1982; 51: 241-250 [PMID: 7146309]
67. Haralambou G, Teirstein AS, Gil J, Present DH. Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med 2001; 68: 384-388 [PMID: 11687866]
68. Gil-Simón P, Barrio Andrés J, Atienza Sánchez R, Julián Gómez L, López Represa C, Caro-Patón A. [Bronchiolitis obliterans organizing pneumonia and Crohn's disease]. Rev Esp Enferm Dig 2008; 100: 175-177 [PMID: 18416645]
69. Aydoʇdu M, Gürsel G, Özyilmaz E, Akyürek N, Memiş L. A case of ulcerative colitis complicated with bronchiolitis obliterans organizing pneumonia (BOOP) and air leak syndrome. Turk J Gastroenterol 2012; 23: 590-595 [PMID: 23161307]
70. Carratú P, Dragonieri S, Nocerino MC, Trabucco SM, Lacedonia D, Parisi G, Resta O. A case of cryptogenic organizing pneumonia occurring in Crohn's disease. Can Respir J 2005; 12: 437-439 [PMID: 16331316]
71. Kim JH, Lee JH, Koh ES, Park SW, Jang AS, Kim D, Park CS. Acute eosinophilic pneumonia related to a mesalazine suppository. Asia Pac Allergy 2013; 3: 136-139 [PMID: 23667838 DOI: 10.5415/apallergy.2013.3.2.136]
72. Hotermans G, Benard A, Guenanen H, Demarcq-Delerue G, Malart T, Wallaert B. Nongranulomatous interstitial lung disease in Crohn's disease. Eur Respir J 1996; 9: 380-382 [PMID: 8777981 DOI: 10.1183/09031936.96.09020380]
73. Meadway J. Ulcerative colitis, colitic spondylitis and associated apical pulmonary fibrosis. Proc R Soc Med 1974; 67: 324-325 [PMID: 4835275]
74. McKee AL, Rajapaksa A, Kalish PE, Pitchumoni CS. Severe interstitial pulmonary fibrosis in a patient with chronic ulcerative colitis. Am J Gastroenterol 1983; 78: 86-89 [PMID: 6130700]
75. Teague WG, Sutphen JL, Fechner RE. Desquamative interstitial pneumonitis complicating inflammatory bowel disease of childhood. J Pediatr Gastroenterol Nutr 1985; 4: 663-667 [PMID: 2863342 DOI: 10.1097/00005176-198508000-00030]
76. Balestra DJ, Balestra ST, Wasson JH. Ulcerative colitis and steroid-responsive, diffuse interstitial lung disease. A trial of N = 1. JAMA 1988; 260: 62-64 [PMID: 3379724 DOI: 10.1001/jama.260.1.62]
77. Chikano S, Sawada K, Ohnishi K, Fukunaga K, Tanaka J, Shimoyama T. Interstitial pneumonia accompanying ulcerative colitis. Intern Med 2001; 40: 883-886 [PMID: 11579949 DOI: 10.2169/internalmedicine.40.883]
78. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301-1315 [PMID: 9563754 DOI: 10.1164/ajrccm.157.4.9707039]
79. Isenberg JI, Goldstein H, Korn AR, Ozeran RS, Rosen V. Pulmonary vasculitis - an uncommon complication of ulcerative colitis. Report of a case. N Engl J Med 1968; 279: 1376-1377 [PMID: 5697529 DOI: 10.1056/NEJM196812192792506]
80. Forrest JA, Shearman DJ. Pulmonary vasculitis and ulcerative colitis. Am J Dig Dis 1975; 20: 482-486 [PMID: 1130374 DOI: 10.1007/BF01070795]
81. Collins WJ, Bendig DW, Taylor WF. Pulmonary vasculitis complicating childhood ulcerative colitis. Gastroenterology 1979; 77: 1091-1093 [PMID: 582812]
82. Mazer BD, Eigen H, Gelfand EW, Brugman SM. Remission of interstitial lung disease following therapy of associated ulcerative colitis. Pediatr Pulmonol 1993; 15: 55-59 [PMID: 8093553]
83. Beer TW, Edwards CW. Pulmonary nodules due to reactive systemic amyloidosis (AA) in Crohn's disease. Thorax 1993; 48: 1287-1288 [PMID: 8303644 DOI: 10.1136/thx.48.12.1287]
84. Puntis JW, Tarlow MJ, Raafat F, Booth IW. Crohn's disease of the lung. Arch Dis Child 1990; 65: 1270-1271 [PMID: 2248544 DOI: 10.1136/adc.65.11.1270]
85. Kayser K, Probst F, Gabius HJ, Müller KM. Are there characteristic alterations in lung tissue associated with Crohn's disease? Pathol Res Pract 1990; 186: 485-490 [PMID: 2247378 DOI: 10.1016/S0344-0338(11)80468-1]
86. Hardarson S, Labrecque DR, Mitros FA, Neil GA, Goeken JA. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis. Am J Clin Pathol 1993; 99: 277-281 [PMID: 8447289]
87. Fellermann K, Stahl M, Dahlhoff K, Amthor M, Ludwig D, Stange EF. Crohn's disease and sarcoidosis: systemic granulomatosis? Eur J Gastroenterol Hepatol 1997; 9: 1121-1124 [PMID: 9431906]
88. Fries W, Grassi SA, Leone L, Giacomin D, Galeazzi F, Naccarato R, Martin A. Association between inflammatory bowel disease and sarcoidosis. Report of two cases and review of the literature. Scand J Gastroenterol 1995; 30: 1221-1223 [PMID: 9053978]
89. Storch I, Rosoff L, Katz S. Sarcoidosis and inflammatory bowel disease. J Clin Gastroenterol 2001; 33: 345 [PMID: 11588558 DOI: 10.1097/00004836-200110000-00023]
90. Krishnan S, Banquet A, Newman L, Katta U, Patil A, Dozor AJ. Lung lesions in children with Crohn's disease presenting as nonresolving pneumonias and response to infliximab therapy. Pediatrics 2006; 117: 1440-1443 [PMID: 16585347 DOI: 10.1542/peds.2005-1559]
91. Freeman HJ, Davis JE, Prest ME, Lawson EJ. Granulomatous bronchiolitis with necrobiotic pulmonary nodules in Crohn's disease. Can J Gastroenterol 2004; 18: 687-690 [PMID: 15565210]
92. Principi M, Mastrolonardo M, Scicchitano P, Gesualdo M, Sassara M, Guida P, Bucci A, Zito A, Caputo P, Albano F, Ierardi E, Di Leo A, Ciccone MM. Endothelial function and cardiovascular risk in active inflammatory bowel diseases. J Crohns Colitis 2013; 7: e427-e433 [PMID: 23473915 DOI: 10.1016/j.crohns.2013.02.001]
93. Papa A, Scaldaferri F, Danese S, Guglielmo S, Roberto I, Bonizzi M, Mocci G, Felice C, Ricci C, Andrisani G, Fedeli G, Gasbarrini G, Gasbarrini A. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. Dig Dis 2008; 26: 149-155 [PMID: 18431065 DOI: 10.1159/000116773]
94. Bernstein CN, Nabalamba A. Hospitalization-based major comorbidity of inflammatory bowel disease in Canada. Can J Gastroenterol 2007; 21: 507-511 [PMID: 17703250]
95. Miehsler W, Reinisch W, Valic E, Osterode W, Tillinger W, Feichtenschlager T, Grisar J, Machold K, Scholz S, Vogelsang H, Novacek G. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 2004; 53: 542-548 [PMID: 15016749 DOI: 10.1136/gut.2003.025411]
96. Bernstein CN, Blanchard JF, Houston DS, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85: 430-434 [PMID: 11307809]
97. Quera R, Shanahan F. Thromboembolism - an important manifestation of inflammatory bowel disease. Am J Gastroenterol 2004; 99: 1971-1973 [PMID: 15447758 DOI: 10.1111/j.1572-0241.2004.40923.x]
98. Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004; 99: 97-101 [PMID: 14687149 DOI: 10.1046/ j.1572-0241.2003.04026.x]
99. Di Fabio F, Lykoudis P, Gordon PH. Thromboembolism in inflammatory bowel disease: an insidious association requiring a high degree of vigilance. Semin Thromb Hemost 2011; 37: 220-225 [PMID: 21455856 DOI: 10.1055/s-0031-1273086]
100. Faller M, Gasser B, Massard G, Pauli G, Quoix E. Pulmonary migratory infiltrates and pachypleuritis in a patient with Crohn's disease. Respiration 2000; 67: 459-463 [PMID: 10940806 DOI: 10.1159/000029550]
101. Patwardhan RV, Heilpern RJ, Brewster AC, Darrah JJ. Pleuropericarditis: an extraintestinal complication of inflammatory bowel disease. Report of three cases and review of literature. Arch Intern Med 1983; 143: 94-96 [PMID: 6849612 DOI: 10.1001/archinte.1983.00350010098017]
102. Orii S, Chiba T, Nakadate I, Fujiwara T, Ito N, Ishii M, Oana S, Chida T, Kudara N, Terui T, Yamaguchi T, Suzuki K. Pleuropericarditis and disseminated intravascular coagulation in ulcerative colitis. J Clin Gastroenterol 2001; 32: 251-254 [PMID: 11246357 DOI: 10.1097/00004836-200103000-00017]
103. Abu-Hijleh M, Evans S, Aswad B. Pleuropericarditis in a patient with inflammatory bowel disease: a case presentation and review of the literature. Lung 2010; 188: 505-510 [PMID: 20827555 DOI: 10.1007/s00408-010-9259-y]
104. Smith PA, Crampton JR, Pritchard S, Li C. Pneumothorax as a presenting feature of granulomatous disease of the lung in a patient with Crohn's disease. Eur J Gastroenterol Hepatol 2009; 21: 237-240 [PMID: 19212215]
105. Desai D, Patil S, Udwadia Z, Maheshwari S, Abraham P, Joshi A. Pulmonary manifestations in inflammatory bowel disease: a prospective study. Indian J Gastroenterol 2011; 30: 225-228 [PMID: 21935713 DOI: 10.1007/s12664-011-0129-1]
106. Mukhopadhyay D, Nasr K, Grossman BJ, Kirsner JB. Pericarditis associated with inflammatory bowel disease. JAMA 1970; 211: 1540-1542 [PMID: 5467054 DOI: 10.1001/jama.211.9.1540]
107. Singh D, Cole JC, Cali RL, Finical EJ, Proctor DD. Colobronchial fistula: an unusual complication of Crohn's disease. Am J Gastroenterol 1994; 89: 2250-2252 [PMID: 7977257]
108. Nielsen OH, Rogler G, Hahnloser D, Thomsen OØ. Diagnosis and management of fistulizing Crohn's disease. Nat Clin Pract Gastroenterol Hepatol 2009; 6: 92-106 [PMID: 19153563 DOI: 10.1038/ncpgasthep1340]
109. Karmy-Jones R, Chagpar A, Vallieres E, Hamilton S. Colobronchial fistula due to Crohn's disease. Ann Thorac Surg 1995; 60: 446-448 [PMID: 7646116 DOI: 10.1016/0003-4975(95 )00207-2]
110. Domej W, Kullnig P, Petritsch W, Melisch B, Schaflinger E, Smolle-Jüttner FM, Schalk V, Ratschek M. Colobronchial fistula: a rare complication of Crohn's colitis. Am Rev Respir Dis 1990; 142: 1225-1227 [PMID: 2240849]
111. Flueckiger F, Kullnig P, Melzer G, Posch E. Colobronchial and gastrocolic fistulas: rare complication of Crohn's disease. Gastrointest Radiol 1990; 15: 288-290 [PMID: 2210196 DOI: 10.1007/BF01888799]
112. Mera A, Sugimoto M, Fukuda K, Tanaka F, Imamura F, Matsuda M, Ando M, Shima K. Crohn's disease associated with colo-bronchial fistula. Intern Med 1996; 35: 957-960 [PMID: 9030994 DOI: 10.2169/internalmedicine.35.957]
113. Gumbo T, Rice TW, Mawhorter S. Recurrent pneumonia from an ileobronchial fistula complicating Crohn's disease. J Clin Gastroenterol 2001; 32: 365-367 [PMID: 11276288]
114. Ho IK, Guarino DP, Pertsovskiy Y, Cerulli MA. Infliximab treatment of an esophagobronchial fistula in a patient with extensive Crohn's disease of the esophagus. J Clin Gastroenterol 2002; 34: 488-489 [PMID: 11907371]
115. Rieder F, Hamer O, Gelbmann C, Schölmerich J, Gross V, Feuerbach S, Herfarth H, Rogler G. Crohn's disease of the esophagus: treatment of an esophagobronchial fistula with the novel liquid embolic polymer "onyx". Z Gastroenterol 2006; 44: 599-602 [PMID: 16823701 DOI: 10.1055/s-2006-926644]
116. Mercadal NR, Wiebke EA. Recurrent pneumonia and colobronchial fistula from Crohn's disease: Infliximab alters and simplifies surgical management. Ann Gastroenterol 2012; 25: 361-364 [PMID: 24714263]
117. Alameel T, Maclean DA, Macdougall R. Colobronchial fistula presenting with persistent pneumonia in a patient with Crohn's disease: a case report. Cases J 2009; 2: 9114 [PMID: 20062691 DOI: 10.1186/1757-1626-2-9114]
118. Barisiae G, Krivokapiae Z, Adziae T, Pavloviae A, Popoviae M, Gojniae M. Fecopneumothorax and colopleural fistula - uncommon complications of Crohn's disease. BMC Gastroenterol 2006; 6: 17 [PMID: 16756646]
119. Pasquis P, Colin R, Denis P, Baptiste P, Galmiche JP, Hecketsweiler P. Transient pulmonary impairment during attacks of Crohn's disease. Respiration 1981; 41: 56-59 [PMID: 7244392 DOI: 10.1159/000194359]
120. Godet PG, Cowie R, Woodman RC, Sutherland LR. Pulmonary function abnormalities in patients with ulcerative colitis. Am J Gastroenterol 1997; 92: 1154-1156 [PMID: 9219789]
121. Tiwary RS, Pruthi HS, Lakhera SC, Kain TC. Pulmonary functions in ulcerative colitis. J Assoc Physicians India 1989; 37: 773-774 [PMID: 2636583]
122. Tzanakis N, Bouros D, Samiou M, Panagou P, Mouzas J, Manousos O, Siafakas N. Lung function in patients with inflammatory bowel disease. Respir Med 1998; 92: 516-522 [PMID: 9692115 DOI: 10.1016/S0954-6111(98)90301-8]
123. Munck A, Murciano D, Pariente R, Cezard JP, Navarro J. Latent pulmonary function abnormalities in children with Crohn's disease. Eur Respir J 1995; 8: 377-380 [PMID: 7789480 DOI: 10.1183/09031936.95.08030377]
124. Eade OE, Smith CL, Alexander JR, Whorwell PJ. Pulmonary function in patients with inflammatory bowel disease. Am J Gastroenterol 1980; 73: 154-156 [PMID: 6104919]
125. Louis E, Louis R, Drion V, Bonnet V, Lamproye A, Radermecker M, Belaiche J. Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy 1995; 50: 729-733 [PMID: 8546267 DOI: 10.1111/j.1398-9995.1995.tb01214.x]
126. Marvisi M, Borrello PD, Brianti M, Fornarsari G, Marani G, Guariglia A. Changes in the carbon monoxide diffusing capacity of the lung in ulcerative colitis. Eur Respir J 2000; 16: 965-968 [PMID: 11153600 DOI: 10.1183/09031936.00.16596500]
127. Mansi A, Cucchiara S, Greco L, Sarnelli P, Pisanti C, Franco MT, Santamaria F. Bronchial hyperresponsiveness in children and adolescents with Crohn's disease. Am J Respir Crit Care Med 2000; 161: 1051-1054 [PMID: 10712362 DOI: 10.1164/ajrccm.161.3.9906013]
128. Herrlinger KR, Noftz MK, Dalhoff K, Ludwig D, Stange EF, Fellermann K. Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission. Am J Gastroenterol 2002; 97: 377-381 [PMID: 11866276 DOI: 10.1111/j.1572-0241.2002.05473.x]
129. Welsh L, Haller W, King LE, Soto-Martinez M, Oliver M, Catto-Smith A, Robinson PJ. Pulmonary function abnormalities in children with active Crohn's disease. Am J Respir Crit Care Med 2012; 186: 1060-1061 [PMID: 23155218 DOI: 10.1164/ajrccm.186.10.1060]
130. MikhaѤlova ZF, Parfenov AI, Ruchkina IN, Rogozina VA. [External respiratory function in patients with Crohn' s disease]. Eksp Klin Gastroenterol 2011; ( 2 ): 82-85 [PMID: 21560645]
131. Tzanakis N, Samiou M, Bouros D, Mouzas J, Kouroumalis E, Siafakas NM. Small airways function in patients with inflammatory bowel disease. Am J Respir Crit Care Med 1998; 157: 382-386 [PMID: 9476847 DOI: 10.1164/ajrccm.157.2.97-04075]
132. Neilly JB, Main AN, McSharry C, Murray J, Russell RI, Moran F. Pulmonary abnormalities in Crohn's disease. Respir Med 1989; 83: 487-491 [PMID: 2623217 DOI: 10.1016/S0954-6111(89)80132-5]
133. Sommer H, Schmidt M, Gruber KD. [Pulmonary functional disorders in ulcerative colitis and Crohn's disease]. Dtsch Med Wochenschr 1986; 111: 812-815 [PMID: 3698863]
134. Wallaert B, Colombel JF, Tonnel AB, Bonniere P, Cortot A, Paris JC, Voisin C. Evidence of lymphocyte alveolitis in Crohn's disease. Chest 1985; 87: 363-367 [PMID: 3971763 DOI: 10.1378/chest.87.3.363]
135. Ateş F, Karincaoʇlu M, Hacievliyagil SS, Yalniz M, Sec¸kin Y. Alterations in the pulmonary function tests of inflammatory bowel diseases. Turk J Gastroenterol 2011; 22: 293-299 [PMID: 21805420]
136. Mohamed-Hussein AA, Mohamed NA, Ibrahim ME. Changes in pulmonary function in patients with ulcerative colitis. Respir Med 2007; 101: 977-982 [PMID: 17049827 DOI: 10.1016/j.rmed.2006.09.005]
137. Wallaert B, Aerts C, Bonniere P, Cortot A, Tonnel AB, Paris JC, Voisin C. Superoxide anion generation by alveolar macrophages in Crohn's disease. N Engl J Med 1985; 312: 444-445 [PMID: 2982094]
138. Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989; 111: 641-649 [PMID: 2802419 DOI: 10.7326/0003-4819-1 11-8-641]
139. Nagy F, Molnar T, Makula E, Kiss I, Milassin P, Zollei E, Tiszlavicz L, Lonovics J. A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine. World J Gastroenterol 2007; 13: 316-319 [PMID: 17226917]
140. Ananthakrishnan AN, Attila T, Otterson MF, Lipchik RJ, Massey BT, Komorowski RA, Binion DG. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease. J Clin Gastroenterol 2007; 41: 682-688 [PMID: 17667053 DOI: 10.1097/01.mcg.0000225577.81008.ee]
141. Fauroux B, Meyer-Milsztain A, Boccon-Gibod L, Leverger G, Clément A, Biour M, Tournier G. Cytotoxic druginduced pulmonary disease in infants and children. Pediatr Pulmonol 1994; 18: 347-355 [PMID: 7892068 DOI: 10.1002/ppul.1950180602]
142. Bedrossian CW, Sussman J, Conklin RH, Kahan B. Azathi-oprine-associated interstitial pneumonitis. Am J Clin Pathol 1984; 82: 148-154 [PMID: 6380265]
143. Bitton A, Peppercorn MA, Hanrahan JP, Upton MP. Mesa-lamine-induced lung toxicity. Am J Gastroenterol 1996; 91: 1039-1040 [PMID: 8633548]
144. Alskaf E, Aljoudeh A, Edenborough F. Mesalazine-induced lung fibrosis. BMJ Case Rep 2013; 2013: [PMID: 23576654 DOI: 10.1136/bcr-2013-008724]
145. Pascual-Lledó JF, Calvo-Bonachera J, Carrasco-Miras F, Sanchez-Martínez H. Interstitial pneumonitis due to mesalamine. Ann Pharmacother 1997; 31: 499 [PMID: 9101017]
146. Trisolini R, Dore R, Biagi F, Luinetti O, Pochetti P, Carrabino N, Luisetti M. Eosinophilic pleural effusion due to mesalamine. Report of a rare occurrence. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 288-291 [PMID: 11033846]
147. Saltzman K, Rossoff LJ, Gouda H, Tongia S. Mesalamineinduced unilateral eosinophilic pneumonia. AJR Am J Roentgenol 2001; 177: 257 [PMID: 11418451 DOI: 10.2214/ajr.177.1.1770257]
148. Yaffe BH, Korelitz BI. Sulfasalazine pneumonitis. Am J Gastroenterol 1983; 78: 493-494 [PMID: 6136183]
149. Park JE, Hwangbo Y, Chang R, Chang YW, Jang JY, Kim BH, Dong SH, Kim HJ. [Mesalazine-induced eosinophilic pneumonia in a patient with Crohn's disease]. Korean J Gastroenterol 2009; 53: 116-120 [PMID: 19237838]
150. Tanigawa K, Sugiyama K, Matsuyama H, Nakao H, Kohno K, Komuro Y, Iwanaga Y, Eguchi K, Kitaichi M, Takagi H. Mesalazine-induced eosinophilic pneumonia. Respiration 1999; 66: 69-72 [PMID: 9973695 DOI: 10.1159/000029341]
151. Cilloniz R, Chesrown SE, Gonzalez-Peralta RP. Asymptomatic presentation of mesalamine-induced lung injury in an adolescent with Crohn disease. BMJ Case Rep 2009; 2009: [PMID: 21686567 DOI: 10.1136/bcr.09.2008.0908]
152. Sossai P, Cappellato MG, Stefani S. Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine. Mt Sinai J Med 2001; 68: 389-395 [PMID: 11687867]
153. Parry SD, Barbatzas C, Peel ET, Barton JR. Sulphasalazine and lung toxicity. Eur Respir J 2002; 19: 756-764 [PMID: 11999006 DOI: 10.1183/09031936.02.00267402]
154. Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989; 110: 353-356 [PMID: 2492786 DOI: 10.7326/0003-4819-110-5-353]
155. Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000; 15: 373-381 [PMID: 10706507 DOI: 10.1034/j.1399-3003.2000.15b25.x]
156. Sostman HD, Matthay RA, Putman CE, Smith GJ. Methotrex-ate-induced pneumonitis. Medicine (Baltimore) 1976; 55: 371-388 [PMID: 957997 DOI: 10.1097/00005792-197609000-00002]
157. White DA, Rankin JA, Stover DE, Gellene RA, Gupta S. Methotrexate pneumonitis. Bronchoalveolar lavage findings suggest an immunologic disorder. Am Rev Respir Dis 1989; 139: 18-21 [PMID: 2521438 DOI: 10.1164/ajrccm/139.1.18]
158. Margagnoni G, Papi V, Aratari A, Triolo L, Papi C. Metho-trexate-induced pneumonitis in a patient with Crohn's disease. J Crohns Colitis 2010; 4: 211-214 [PMID: 21122509 DOI: 10.1016/j.crohns.2009.11.007]
159. Brechmann T, Heyer C, Schmiegel W. [Methotrexate-induced pneumonitis in a woman with Crohn's disease]. Dtsch Med Wochenschr 2007; 132: 1759-1762 [PMID: 17713885 DOI: 10.1055/s-2007-984962]
160. Karoli NA, Rebrov AP, Roshchina AA, Steshenko RN, Bukiia AS. [Iatrogenic lung diseases]. Klin Med (Mosk) 2012; 90: 70-72 [PMID: 22896987]
161. Rutgeerts P, Vermeire S, Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology 2009; 136: 1182-1197 [PMID: 19249397 DOI: 10.1053/j.gastro.2009.02.001]
162. Ghosh S. Anti-TNF therapy in Crohn's disease. Novartis Found Symp 2004; 263: 193-205; discussion 205-218 [PMID: 15669643 DOI: 10.1002/0470090480.ch14]
163. Cheifetz AS. Management of active Crohn disease. JAMA 2013; 309: 2150-2158 [PMID: 23695484 DOI: 10.1001/jama.2013.4466]
164. Hoentjen F, van Bodegraven AA. Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease. World J Gastroenterol 2009; 15: 2067-2073 [PMID: 19418577 DOI: 10.3748/wjg.15.2067]
165. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. Tuberculosis associated with infliximab, a tumor necrosis factor alphaneutralizing agent. N Engl J Med 2001; 345: 1098-1104 [PMID: 11596589 DOI: 10.1056/NEJMoa011110]
166. Mayordomo L, Marenco JL, Gomez-Mateos J, Rejon E. Pulmonary miliary tuberculosis in a patient with anti-TNFalpha treatment. Scand J Rheumatol 2002; 31: 44-45 [PMID: 11922200 DOI: 10.1080/030097402317255372]
167. Milenković B, Dudvarski-Ilić A, Janković G, Martinović L, Mijac D. Anti-TNF treatment and miliary tuberculosis in Crohn's disease. Srp Arh Celok Lek 2007; 139: 514-517 [PMID: 21980664 DOI: 10.2298/SARH1108514M]
168. Kaur N, Mahl TC. Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases. Dig Dis Sci 2007; 52: 1481-1484 [PMID: 17429728 DOI: 10.1007/s10620-006-9250-x]
169. Colombel JF, Loftus EV, Tremaine WJ, Egan LJ, Harmsen WS, Schleck CD, Zinsmeister AR, Sandborn WJ. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 2004; 126: 19-31 [PMID: 14699483 DOI: 10.1053/j.gastro.2003.10.047]
170. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc 2008; 83: 181-194 [PMID: 18241628 DOI: 10.1016/S0025-6196(11)60839-2]
171. Cohen RD, Bowie WR, Enns R, Flint J, Fitzgerald JM. Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease. Thorax 2007; 62: 1013-1014 [PMID: 17965080 DOI: 10.1136/thx.2006.075150]
172. Kasai S, Tokuda H, Otsuka Y, Ookohchi Y, Handa H, Emoto N, Yoshikawa M. [Two cases of respiratory infection complicating treatment with infliximab]. Nihon Kokyuki Gakkai Zasshi 2007; 45: 366-371 [PMID: 17491318]
173. Stratakos G, Kalomenidis I, Papas V, Malagari K, Kollintza A, Roussos C, Anagnostopoulou M, Paniara O, Zakynthinos S, Papiris SA. Cough and fever in a female with Crohn' s disease receiving infliximab. Eur Respir J 2005; 26: 354-357 [PMID: 16055885 DOI: 10.1183/09031936.05.00005205]
174. Toruner M, Loftus EV, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008; 134: 929-936 [PMID: 18294633 DOI: 10.1053/j.gastro.2008.01.012]
175. Riegert-Johnson DL, Godfrey JA, Myers JL, Hubmayr RD, Sandborn WJ, Loftus EV. Delayed hypersensitivity reaction and acute respiratory distress syndrome following infliximab infusion. Inflamm Bowel Dis 2002; 8: 186-191 [PMID: 11979139 DOI: 10.1097/00054725-200205000-00005]
176. Panagi S, Palka W, Korelitz BI, Taskin M, Lessnau KD. Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease. Inflamm Bowel Dis 2004; 10: 274-277 [PMID: 15290924]
177. Reid JD, Bressler B, English J. A case of adalimumab-induced pneumonitis in a 45-year-old man with Crohn's disease. Can Respir J 2011; 18: 262-264 [PMID: 21969926]
178. Ostör AJ, Chilvers ER, Somerville MF, Lim AY, Lane SE, Crisp AJ, Scott DG. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. J Rheumatol 2006; 33: 622-628 [PMID: 16511933]
179. Ramos-Casals M, Brito-Zerón P, Muñoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 2007; 86: 242-251 [PMID: 17632266 DOI: 10.1097/MD.0b013e3181441a68]
180. Villeneuve E, St-Pierre A, Haraoui B. Interstitial pneumonitis associated with infliximab therapy. J Rheumatol 2006; 33: 1189-1193 [PMID: 16622902]